About

Dr. Bryan J. Sandler is a leading figure in minimally invasive and robotic foregut surgery, with a research focus on optimizing outcomes for esophageal, bariatric, and hernia procedures. He has been instrumental in demonstrating the safety and efficacy of the da Vinci® Surgical System, notably authoring the pivotal SAGES TAVAC analysis (74 citations) that validated its use. Dr. Sandler pioneered the robotic-assisted transhiatal esophagectomy (RATE) for esophageal cancer, proving it can be performed safely even after neoadjuvant chemoradiation (33 citations), and developed an innovative intraoperative endoscopic Botox injection technique to prevent the need for pyloromyotomy during esophagectomy (27 citations). His work extends to bariatric surgery, where a recent MBSAQIP analysis of over 40,000 cases (25 citations) showed that robotic revisional gastric bypass reduces morbidity compared to laparoscopic approaches. Dr. Sandler has also advanced Enhanced Recovery After Surgery (ERAS) protocols, demonstrating decreased urinary retention in hernia repair (24 citations). With over 240 combined citations, his contributions have shaped safer, more effective surgical standards in complex foregut and bariatric care.

Research Focus

Key Achievements

9
H-Index
12
Papers
244
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
SAGES TAVAC safety and effectiveness analysis: da Vinci® Surgical System (Intuitive Surgical, Sunnyvale, CA)
74 citations · 2015
📈 Most Prolific Year: 2016 (2 Papers)
🤝 Key Collaborators: 57
🏛 Institutions: University of California San Diego, VA San Diego Healthcare System, University of San Diego, University of California San Diego Medical Center, Institute for the Future

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago